Durham, North Carolina 27705


This is a research study determining whether subjects who receive their after-transplant care in the home compared to subjects who receive their care in the hospital, have a lower chance of developing graft versus-host-disease (GVHD) after 6 months and improved quality of life.


Patient Inclusion Criteria: - Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer or non-cancer illness - Age 18-80 years - Karnofsky Performance Scale KPS> 80 - A home that is deemed, upon inspection, in suitable condition to serve as a medical home, within a 90-minute driving distance of Duke Patient Exclusion Criteria: - Lack of a caregiver - Pregnant women - Patients with a documented active infection prior to starting their preparative regimen. This includes grade 3 or higher viral, bacterial, or fungal infection. - Use of homeopathic medications, prebiotics, or probiotics that may impact gut microbiota Caregiver Inclusion Criteria: - Identified by patient as their primary caregiver - Meet standard clinical criteria for being a caregiver (able to drive and take care of patient) - Age 18-80 years Caregiver Exclusion Criteria:



Primary Contact:

Principal Investigator
Anthony Sung, MD
Duke University Health System

Krista Rowe, RN
Phone: 9196847115
Email: krista.rowe@duke.edu

Backup Contact:


Location Contact:

Durham, North Carolina 27705
United States

Anthony Sung, MD
Phone: 919-668-5710
Email: anthony.sung@duke.edu

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.